Galectin Therapeutics (GALT) Dividends payables (2010 - 2025)
Galectin Therapeutics (GALT) recorded quarterly Dividends payables of $63000.0 in Q4 2025, little changed quarter-over-quarter from $63000.0 in Q2 2025, and little changed on a YoY basis from $63000.0 in Q4 2024.
Galectin Therapeutics (GALT) Dividends payables (2010 - 2025) Analysis & Trends
Galectin Therapeutics' Dividends payables history runs 16 years deep, the most recent figure standing at $63000.0 for Q4 2025.
- In Q4 2025, Dividends payables changed 0.0% year-over-year to $63000.0; the TTM figure through Dec 2025 stood at $63000.0 (changed 0.0% YoY), while the FY2025 annual figure was $63000.0, changed 0.0% from the prior year.
- Dividends payables was $63000.0 for Q4 2025 at Galectin Therapeutics, roughly flat from $63000.0 in the prior quarter.
- In the past five years, Dividends payables ranged from a high of $65000.0 in Q2 2021 to a low of $63000.0 in Q4 2023.
- Historically, Dividends payables has averaged $63700.0 across 5 years, with a median of $63500.0 in 2022.
- The sharpest annual moves came in 2021 and 2023: Dividends payables changed 0.0% in 2021, then dropped 1.56% in 2023.
- A 5-year view of Dividends payables shows it stood at $65000.0 in 2021, then fell by 1.54% to $64000.0 in 2022, then decreased by 1.56% to $63000.0 in 2023, then changed by 0.0% to $63000.0 in 2024, then changed by 0.0% to $63000.0 in 2025.
- The last three Dividends payables figures came in at $63000.0 (Q4 2025), $63000.0 (Q2 2025), and $63000.0 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Galectin Therapeutics | 185.83 Mn | 171.73 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 63,000.00 |
| Jun 30, 2025 | 63,000.00 |
| Dec 31, 2024 | 63,000.00 |
| Jun 30, 2024 | 63,000.00 |
| Dec 31, 2023 | 63,000.00 |
| Jun 30, 2023 | 64,000.00 |
| Dec 31, 2022 | 64,000.00 |
| Jun 30, 2022 | 64,000.00 |
| Dec 31, 2021 | 65,000.00 |
| Jun 30, 2021 | 65,000.00 |
| Dec 31, 2020 | 65,000.00 |
| Jun 30, 2020 | 66,000.00 |
| Dec 31, 2019 | 66,000.00 |
| Jun 30, 2019 | 66,000.00 |
| Dec 31, 2018 | 299,000.00 |
| Jun 30, 2018 | 67,000.00 |
| Dec 31, 2017 | 68,000.00 |
| Jun 30, 2017 | 68,000.00 |
| Dec 31, 2016 | 68,000.00 |
| Jun 30, 2016 | 68,000.00 |